Abstract
Background: The adoption of biomarkers as part of high-throughput, complex microarray or sequencing data has necessitated the discovery and validation of these data through machine learning. Machine learning has remained a fundamental and indispensable tool due to its efficacy and efficiency in both feature extraction of relevant biomarkers as well as the classification of samples as validation of the discovered biomarkers.
Objectives: This review aims to present the impact and ability of various machine learning methodologies and models to process high-throughput, high-dimensionality data found within mass spectrometry, microarray, and DNA/RNA-sequence data; data that precluded biomarker discovery prior to the use of machine learning.
Methods: A vast array of literature highlighting machine learning for biomarker discovery was reviewed, resulting in the eligibility of 21 machine learning algorithms/networks and 3 combinatory architectures, spanning 17 fields of study. This literature was screened to investigate the usage and development of machine learning within the framework of biomarker discovery.
Results: Out of the 93 papers collected, a total of 62 biomarker studies were further reviewed across different subfields-49 of which employed machine learning algorithms, and 13 of which employed neural network-based models. Through the application, innovation, and creation of tools in biomarker-related machine learning methodologies, its use allowed for the discovery, accumulation, validation, and interpretation of biomarkers within varied data formats, sources, as well as fields of study.
Conclusion: The use of machine learning methodologies for biomarker discovery is critical to the analysis of various types of data used for biomarker discovery, such as mass spectrometry, nucleotide and protein sequencing, and image (e.g. CT-scan) data. Further studies containing more standardized techniques for evaluation, and the use of cutting- edge machine learning architectures may lead to more accurate and specific results.
Keywords: Biomarker discovery, machine learning, neural networks, mass spectrometry, sequencing, microarray.
Current Medicinal Chemistry
Title:Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Volume: 28 Issue: 32
Author(s): Dakila Ledesma*, Steven Symes and Sean Richards
Affiliation:
- Department of Computer Science and Engineering, University of Tennessee at Chattanooga, Tennessee, TN 37996,United States
Keywords: Biomarker discovery, machine learning, neural networks, mass spectrometry, sequencing, microarray.
Abstract:
Background: The adoption of biomarkers as part of high-throughput, complex microarray or sequencing data has necessitated the discovery and validation of these data through machine learning. Machine learning has remained a fundamental and indispensable tool due to its efficacy and efficiency in both feature extraction of relevant biomarkers as well as the classification of samples as validation of the discovered biomarkers.
Objectives: This review aims to present the impact and ability of various machine learning methodologies and models to process high-throughput, high-dimensionality data found within mass spectrometry, microarray, and DNA/RNA-sequence data; data that precluded biomarker discovery prior to the use of machine learning.
Methods: A vast array of literature highlighting machine learning for biomarker discovery was reviewed, resulting in the eligibility of 21 machine learning algorithms/networks and 3 combinatory architectures, spanning 17 fields of study. This literature was screened to investigate the usage and development of machine learning within the framework of biomarker discovery.
Results: Out of the 93 papers collected, a total of 62 biomarker studies were further reviewed across different subfields-49 of which employed machine learning algorithms, and 13 of which employed neural network-based models. Through the application, innovation, and creation of tools in biomarker-related machine learning methodologies, its use allowed for the discovery, accumulation, validation, and interpretation of biomarkers within varied data formats, sources, as well as fields of study.
Conclusion: The use of machine learning methodologies for biomarker discovery is critical to the analysis of various types of data used for biomarker discovery, such as mass spectrometry, nucleotide and protein sequencing, and image (e.g. CT-scan) data. Further studies containing more standardized techniques for evaluation, and the use of cutting- edge machine learning architectures may lead to more accurate and specific results.
Export Options
About this article
Cite this article as:
Ledesma Dakila *, Symes Steven and Richards Sean , Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery, Current Medicinal Chemistry 2021; 28 (32) . https://dx.doi.org/10.2174/0929867328666210208111821
DOI https://dx.doi.org/10.2174/0929867328666210208111821 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Free Radical Attack on Cholesterol: Oxysterols as Markers of Oxidative Stress and as Bioactive Molecules
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy
Current Cancer Drug Targets The Pharmaceutical Potential of Histone Deacetylase Inhibitors
Current Pharmaceutical Design Antibody Targeting of TGF-β in Cancer Patients
Current Pharmaceutical Biotechnology Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology A Brief Survey on Computational Approaches to Reveal Drug and Disease Associations
Current Drug Discovery Technologies Structure-activity Relationship Studies of New Marine Anticancer Agents and their Synthetic Analogues
Current Medicinal Chemistry Recent Advances on Small-Molecule Survivin Inhibitors
Current Medicinal Chemistry The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
Current Cancer Drug Targets Prostaglandin E Synthase: A Novel Drug Target for Inflammation and Cancer
Current Pharmaceutical Design Kinases as Drug Targets in Inflammation: In Vitro and In Vivo Target Validation and Expression Profiling
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
Current Medicinal Chemistry Ethical Implications of Pharmacogenetics: Shaping the Future of the Field
Current Pharmacogenomics Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer
Current Drug Targets Anti-EGFR Strategy for Colorectal Cancer: Searching for the Real Target
Letters in Drug Design & Discovery Estrogen(s) and Analogs as a Non-Immunogenic Endogenous Ligand in Targeted Drug/DNA Delivery
Current Medicinal Chemistry Circulating Cellular Players in Vascular Calcification
Current Pharmaceutical Design Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Opioid Transport by ATP-Binding Cassette Transporters at the Blood-Brain Barrier: Implications for Neuropsychopharmacology
Current Pharmaceutical Design